Evidence of type I and type II transforming growth factor-β receptors in central nervous tissues: Changes induced by focal cerebral ischemia

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2296-2304

  Vivien, Denis ^a   Bernaudin, Myriam ^a   Buisson, Alain ^a   Divoux, Didier ^a   MacKenzie, Eric T ^a   Nouvelot, André ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

CNS; Ischemia; Receptors; Transforming growth factor

Indexed keywords

RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ARTICLE; BRAIN ISCHEMIA; MOUSE; NERVE DEGENERATION; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031799870     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062296.x     Document Type: Article

References (42)

1. Bengtsson H., Söderström S., and Ebendal T. (1995) Expression of activin receptors type I and II only partially overlaps in the nervous system. Neuroreport 7, 113-116.
2. Böttner M., Unsicker K., and Suter-Crazzolara C. (1996) Expression of TGF-β type II receptor mRNA in the CNS. Neuroreport 7, 2903-2907.
3. Buisson A. and Choi D. W. (1995) The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology 34, 1081-1087.
4. Cheifetz S., Hernandez H., Laiho M., ten Dijke P., Iwata K. K., and Massagué J. (1990) Distinct transforming growth factor beta (TGF-β) receptor subsets as determinants of cellular responsiveness to 3 TGF-β isoforms. J. Biol. Chem. 265, 20533-20538.
5. Constam D. B., Philipp J., Malipiero U. V., ten Dijke P., Schachner M., and Fontana A. (1992) Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes and microglia. J. Immunol. 148, 1404-1410.
6. da Cunha A., Jefferson J. J., Tyor W. R., Glass J. D., Jannota F. S., and Viotkovic L. (1993) Control of astrocytosis by interleukin-1 and transforming growth factor beta 1 in human brain. Brain Res. 631, 39-45.
7. Dewulf N., Verschueren K., Lonnoy O., Moren A., Grimsby S., Vande Spiegle K., Miyazono K., Huylebroeck D., and ten Dijke P. (1995) Distinct spatial and temporal expression patterns ot two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136, 2652-2663.
8. Eppert K., Scherer S. W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L. C., Bapat B., Gallinger S., Andrulis I. L., Thomsen G. H., Wrana J. L., and Attisano L. (1996) MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552.
9. Frank S., Madlener M., and Werner S. (1996) Transforming growth factors β1, β2 and β3 and their receptors are differentially regulated during normal and impaired wound healing. J. Biol. Chem. 271, 10188-10193.
10. Franzen P., ten Dijke P., Ichijo H., Heldin C. H., and Miyazono K. (1993) Cloning of a TGF-β type I receptor that forms a heterodimeric complex with the TGF-β type II receptor. Cell 75, 681-692.
11. Gotti B., Benavides J., MacKenzie E. T., and Scatton B. (1990) The pharmacotherapy of focal cortical ischemia in the mouse. Brain Res. 552, 290-307.
12. Harpel G., Metz C. N., Kojima S., and Rifkin D. B. (1992) Control of transforming growth factor β activity: latency vs. activation. Prog. Growth Factor Res. 4, 321-335.
13. Henrich-Noack P., Prehn J. H., and Krieglstein J. (1994) Neuroprotective effects of TGF-β1. J. Neural Transm. Suppl. 43, 33-45.
14. Kim J. Johnson K., Chen H. J., Carrol S., and Laughon A. (1997) Drosophilia Mad binds to DNA and directly mediates activation of vestigial by decapentaplegic peptide. Nature 388, 304-308.
15. Krupinski J., Kumar P., Kumar S., Path F. R. C., and Kaluza J. (1996) Increased expression of TGF-β1 in brain tissue after ischemic stroke in human. Stroke 27, 852-857.
16. Lehrmann E., Kiefer R., Finsen B., Diemer N. H., Zimmer J., and Hartung H. P. (1995) Cytokines in cerebral ischemia: expression of transforming growth factor-beta-1 (TGF-β1) mRNA in the postischemic adult rat hippocampus. Exp. Neurol. 131, 114-123.
17. Lin H. Y., Wane X. F., Ng-Eaton E., Weinberg R. A., and Lodish H. F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.
18. Logan A., Frautschy S. A., Gonzalez A. M., Sporn M. B., and Baird A. (1992) Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res. 587, 216-225.
19. Lorentzon M., Hoffer B., Ebendal T., Olson L., and Tomac A. (1996) Habrec1 a novel serine/threonine kinase TGF-β type I-like receptor has a specific cellular expression suggesting function in the developing organism and adult brain. Exp. Neurol. 142, 351-360.
20. Massagué J. (1987) Identification of receptors ot type β transforming growth factor. Methods Enzymol. 146, 174-195.
21. Massagué J. and Weis-Garcia F. (1996) TGF-βs in cancer, in Cancer Surveys (Pawson T. and Parker P., eds). pp. 620-623. ICRF Press, London.
22. Massagué J., Attisano L., and Wrana J. L. (1994) The TGF-β super-family and its composite receptors. Trends Cell Biol. 4, 172-178.
23. Massagué J., Hata A., and Liu F. (1997) TGF-β signaling through the Smad pathway. Trends Cell Biol. 7, 187-192.
24. McNeill H., Williams C., Guan J., Dragunow M., Lawlor P. Sirimanne E., Nikolics K., and Gluckman P. (1994) Neuronal rescue with transforming growth factor beta 1 after hypoxicischaemic brain injury. Neuroreport 5, 901-904.
25. Morita N., Takumi T., and Kiyama H. (1996) Distinct localization of two serine-threonine kinse receptors for activin and TGF-beta in the rat brain and down regulation of type I activm receptor during peripheral nerve regeneration. Brain Res. Mol. Brain Res. 42, 263-271.
26. Nakao A., Imamura T., Souchelnitsky S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C. H., Miyazono K., and ten Dijke P. (1997) TGF-beta receptor mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362.
27. Poulsen K. T., Armanini M. P., Klein R. D., Hynes M. A., Phillips H. S., and Rosenthal A. (1994) TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13, 1245-1252.
28. Prehn J. H. and Krieglstein J. (1994) Opposing effects of transforming growth factor-beta 1 on glutamate neurotoxicity. Neuroscience 60, 7-10.
29. Prehn J. H., Backhauss C., and Krieglstein J. (1993) Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J. Cereb. Blood Flow Metab. 13, 521-525.
30. Rimaniol A. C., Lekieffre D., Serrano A., Masson A., Benavides J., and Zavala F. (1995) Biphasic transforming growth factor β production flanking the pro-inflammatory cytokine response in cerebral trauma. Neuroreport 7, 133-136.
31. Roberts A. B. and Sporn M. B. (1992) Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol. Reprod. Dev. 32, 91-98.
32. Rose K., Goldberg M. P., and Choi D. W. (1993) Cytotoxicity in murine cortical cell culture, in In Vitro Biological Methods (Tyson C. A. and Frazier J. M., eds). pp. 40-60. Academic Press, San Diego.
33. Shi Y., Hata A., Lo R. S., Massagué J., and Pavletich N. P. (1997) Structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 338, 87-93.
34. Söderstrom S., Bengtsson H., and Ebendal T. (1996) Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain. Cell Tissue Res. 286, 269-279.
35. Souchelnitsky S., Chambaz E. M., and Feige J. J. (1995) Thrompospontin selectively activates one of two latent forms of transforming growth factor β present in adrenocortical cell conditioned medium. Endocrinology 136, 5118 -5126.
36. Tomoda T., Shirasawa T., Yahagi Y., Ishii K., Takagi H. Furiya Y., Arai K., Mori H., and Muramatsu M. (1996) Transforming growth factor-β is a survival factor for neonate cortical neurons: coincident expression of type I receptors in developing cerebral cortices. Dev. Biol. 179, 79-90.
37. Unsicker K., Flanders K. C., Cisscl D. S., Lafyatis R., and Sporn M. B. (1991) Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 44, 613-625.
38. Vivien D. and Wrana J. L. (1995) Ligand induced recruitment and phosphorylation of reduced TGF-β type I receptor. Exp. Cell Res. 221, 60-65.
39. Vivian D., Attisano L., Wrana J. L., and Massagué J. (1995) Signaling activity of homologous and heterologous transforming growth factor-β kinase complexes. J. Biol. Chem. 270, 7134-7141
40. Wrana J. L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., Wang X. F., and Massagué J. (1992) TGF-β signals through a heteromeric protein kinase complex. Cell 71, 1003-1014.
41. Wrana J. L., Attisano L., Wieser R., Ventura F., and Massagué J. (1994) Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
42. Zhang Y., Fen X.-H., Wu R.-Y., and Derinck R. (1996) Receptor associated Mad homologues synergize as effectors ot the TGF-β response. Nature 383, 168-172.